Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 13 announcements

Share price
₹2,380.00
Market cap
₹67,169 Cr
Revenue (annual)
₹16,983 Cr
Net profit (annual)
₹1,362 Cr
P/E (TTM)
37.4×Sector 50.4×
Promoter holding
46.65%+0.00% QoQ
FII holding
20.89%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3Product Launch 1Financial Results 1Credit Rating 1Business Update 1Annual General Meeting 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

1 announcement with these filters

18:39 IST BSE
Financial Results

Glenmark Pharmaceuticals Q1 FY27 Results: Net Profit ₹482.8 Cr, Up 927.2% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹4,018 Cr (+23.1% YoY) and net profit of ₹482.8 Cr (+927.2% YoY) for Q1 FY27.

Key figure
Net profit ₹482.8 Cr · +927.2% YoY
Open full results → Read the filing ↗